Oracle
ORCL
NVIDIA
NVDA
Amazon
AMZN
Adobe
ADBE
Alphabet-A
GOOGL
US Stock MarketDetailed Quotes
RNA Avidity Biosciences
- 31.015
- +2.095+7.24%
Trading Jan 21 15:36 ET
3.70BMarket Cap-10.77P/E (TTM)
31.290High28.590Low976.29KVolume28.590Open28.920Pre Close29.24MTurnover1.06%Turnover RatioLossP/E (Static)119.31MShares56.00052wk High2.46P/B2.86BFloat Cap11.23052wk Low--Dividend TTM92.21MShs Float56.000Historical High--Div YieldTTM9.34%Amplitude4.825Historical Low29.950Avg Price1Lot Size
Avidity Biosciences News
Avidity Biosciences Analyst Ratings
RBC Capital Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $67
Wells Fargo Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $75
BofA Securities Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $51
Bank of America Securities Remains a Buy on Avidity Biosciences (RNA)
Barclays Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $63
Analysts Offer Insights on Healthcare Companies: Avidity Biosciences (RNA), Celldex (CLDX) and Centessa Pharmaceuticals (CNTA)
Wells Fargo Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $75
Avidity Biosciences Analyst Ratings
H.C. Wainwright Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $72
Wells Fargo Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $75
Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Tecan Group AG (OtherTCHBF) and Avidity Biosciences (RNA)
H.C. Wainwright Initiates Avidity Biosciences(RNA.US) With Buy Rating, Announces Target Price $72
What 8 Analyst Ratings Have To Say About Avidity Biosciences
Avidity Biosciences Initiated at Buy by HC Wainwright & Co.
Avidity Biosciences Price Target Announced at $72.00/Share by HC Wainwright & Co.
TD Cowen Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $78
TD Cowen Maintains Avidity Biosciences(RNA.US) With Buy Rating, Maintains Target Price $78
Avidity Biosciences (RNA) Receives a Buy From TD Cowen
Avidity Biosciences Analyst Ratings
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.